Tharos Ltd
Tharos aims to improve the health and welfare of animals by aiding in the maintenance of an optimised microbiome.
Tharos aims to improve the health and welfare of animals by aiding in the maintenance of an optimised microbiome.
Tharos Ltd is a UK-based startup that aims to improve the health and welfare of animals by aiding in the maintenance of an optimised microbiome. The company, founded in 2016, focuses on digestive health, the gut microbiome, and colonic malfermentation in horses. Tharos is committed to promoting equine health and increased well-being through research, discovery, and innovation, harnessing the potential of both science and nature. Their product EQUINECTAR®, developed after four years of groundbreaking research with Cumani Racing and others, is a pioneering solution for digestive issues in performance horses. As a member of the British Equestrian Trade Association (BETA), Tharos presents a compelling opportunity to horse professionals worldwide. The startup operates in the Biotechnology, Health Care, and Sports industries. Tharos received a Seed Round investment on 08 February 2019.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | - | 08 Feb 2019 |
No recent news or press coverage available for Tharos Ltd.
We care about your data, and we'd love to use cookies make your experience better.
